Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Notes Payables: 2019-2020

Historic Notes Payables for Pharming Group N.V (PHAR) over the last 2 years, with Dec 2020 value amounting to -$496,000.

  • Pharming Group N.V's Notes Payables fell 100.97% to -$496,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$496,000, marking a year-over-year decrease of 100.97%. This contributed to the annual value of -$496,000 for FY2020, which is 100.97% down from last year.
  • Pharming Group N.V's Notes Payables amounted to -$496,000 in FY2020, which was down 100.97% from $51.1 million recorded in FY2019.
  • In the past 5 years, Pharming Group N.V's Notes Payables ranged from a high of $51.1 million in FY2019 and a low of -$496,000 during FY2020.
  • In the last 2 years, Pharming Group N.V's Notes Payables had a median value of $25.3 million in 2019 and averaged $25.3 million.
  • Data for Pharming Group N.V's Notes Payables shows a maximum YoY slumped of 100.97% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows Pharming Group N.V's Notes Payables stood at $51.1 million in 2019, then plummeted by 100.97% to -$496,000 in 2020.